Repatriation Medical Authority - Notice of Investigation - Hypopituitarism - focussed

Overview

The Veterans' Entitlements Act 1986 was enacted to provide for veterans' entitlements and related matters. The Act was introduced to address the need for a comprehensive legislative framework governing the entitlements and benefits available to veterans and their families in Australia. The Repatriation Medical Authority (the Authority), as the body established under the VEA, has given notice of its intention to conduct an investigation regarding the definition of hypopituitarism in the context of Statements of Principles Instrument Nos. 11 and 12 of 2019. This investigation aims to gather relevant submissions from eligible claimants, organisations, and experts to ensure a thorough understanding of the condition and its implications for veterans' entitlements. The Authority invites interested parties to submit written submissions by 1 February 2021, either electronically via the RMA website, by email, or by post. The first meeting for this investigation will be held on 10 February 2021. The policy objective of this investigation is to enhance the understanding of hypopituitarism and its impact on veterans' entitlements, ultimately leading to more informed decision-making and appropriate benefits for affected individuals. The Repatriation Medical Authority, under the direction of its Chairperson, Professor Nicholas Saunders AO, is responsible for overseeing this investigation and ensuring the process is conducted in a fair and transparent manner. The RMA Submission Guidelines are available for guidance, and further assistance can be sought from the RMA Secretariat.

Scope and Application

The notice issued by the Repatriation Medical Authority (RMA) under section 196G of the Veterans' Entitlements Act 1986 (VEA) pertains to an investigation concerning the definition of hypopituitarism, specifically in the context of Statements of Principles Instruments Nos. 11 and 12 of 2019. This investigation is directed towards several stakeholders, including individuals eligible to claim pensions under Part II or Part IV of the VEA or compensation under section 319 of the Military Rehabilitation and Compensation Act 2004, organisations representing veterans and related groups, and relevant commissions such as the Repatriation Commission and the Military Rehabilitation and Compensation Commission. Additionally, the RMA invites submissions from experts with relevant field expertise. The geographic scope of this investigation is implicitly national, as the VEA and related legislation apply throughout Australia. There are no explicit exclusions or thresholds mentioned in the notice, but the focus remains on the specific medical condition in question, with the aim of ensuring that the definition aligns with the needs of affected veterans and their families. The RMA, operating under the auspices of the VEA, holds the authority to extend or restrict the application of this investigation through subordinate instruments, although such measures are not detailed in the notice. Submissions must be made in writing and should be submitted electronically via the RMA website, by email, or by post, with a strict deadline of 1 February 2021. The notice also provides contact details for the RMA Secretariat to assist with the submission process, ensuring that interested parties have the necessary support to contribute to the investigation. This initiative is a part of the broader legislative framework designed to safeguard and enhance the entitlements and support available to veterans and their dependents under Australian law.

Key Provisions

The main operative sections of this Notice of Investigation under section 196G of the Veterans' Entitlements Act 1986 (VEA) pertain to the investigation into the definition of hypopituitarism as it relates to Statements of Principles Instrument Nos. 11 and 12 of 2019. The Repatriation Medical Authority (the Authority) has mandated that this investigation be conducted to ensure clarity and comprehensiveness regarding the medical condition in question, as it pertains to the entitlements and compensation claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). This investigation aims to gather comprehensive input from various stakeholders including eligible claimants, representatives of affected groups, and experts in relevant fields. The Authority imposes several obligations on the parties it governs. Firstly, eligible claimants, representatives of affected groups, and experts are invited to submit written submissions to the Authority. These submissions are to be made by 1 February 2021 and can be lodged electronically via the RMA website, emailed to info@rma.gov.au, or posted to a specified address. The RMA Submission Guidelines are available online to assist in preparing these submissions. Additionally, the Authority has scheduled its first meeting for the purposes of this investigation on 10 February 2021. This meeting signifies the formal commencement of the investigation process, where gathered submissions will be reviewed and considered. Breaches of the requirements set out in the Notice of Investigation may lead to consequences under the VEA and MRCA. While the Notice does not explicitly state penalties for non-compliance, it is understood that failing to adhere to the stipulated submission deadlines and guidelines could impact the fairness and thoroughness of the investigation. Furthermore, any failure to comply with the obligations may be viewed as non-cooperation with the statutory duties of the Authority, which could potentially lead to administrative or legal repercussions. The maximum penalties for such breaches are not explicitly detailed in the Notice but are governed by the overarching legislative frameworks of the VEA and MRCA, which could include fines or other sanctions as deemed appropriate by the relevant authorities.